Not finding it? Sign in to also search OpenAlex live.
-
Indirect Treatment Comparisons of Daratumumab, Pomalidomide, and Dexamethasone Versus Daratumumab, Bortezomib, and Dexamethasone or Bortezomib and Dexamethasone in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma
Jianming He, Heather Berringer, Bart M. S. Heeg, Tobias Kampfenkel, João Mendes, Annette Lam, +1 more
1citations -
Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones2020 The Journal of Clinical Endocrinology & Metabolism article Medicine Bone health and osteoporosis research Open access
Sebastian E.E. Schagen, Femke M. Wouters, Peggy T. Cohen‐Kettenis, Louis J. Gooren, Sabine Elisabeth Hannema
127citations -
Migration of a novel 3D-printed cementless versus a cemented total knee arthroplasty: two-year results of a randomized controlled trial using radiostereometric analysis
Shaho Hasan, Koen T. van Hamersveld, Perla J. Marang‐van de Mheen, Bart L. Kaptein, Rob G. H. H. Nelissen, Søren Toksvig‐Larsen
74citations -
Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia2020 Therapeutic Advances in Psychopharmacology article Medicine Schizophrenia research and treatment Open access
María Paz García‐Portilla, Pierre‐Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Özgüven, Sung‐Wan Kim, +3 more
44citations -
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes2023 American Journal of Cardiovascular Drugs article Medicine Heart Failure Treatment and Management Open access
M. Böttcher, Hans‐Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr, Pim Gal, +8 more
14citations -
L2M-AID: Autonomous Cyber-Physical Defense by Fusing Semantic Reasoning of Large Language Models with Multi-Agent Reinforcement Learning5citations
-
S183: PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
Phillip Scheinberg, Diego V. Clé, Valentina Giai, Marek Hus, Jin Seok Kim, Cristina Barrenetxea Lekue, +11 more
5citations